Targeted Immunotherapy Transforming the HER2 Antibodies Market Landscape
The global HER2 antibodies market is witnessing consistent growth, driven by the increasing prevalence of HER2-positive cancers and rapid advancements in targeted cancer therapies. Valued at US$ 9.0 billion in 2023, the market is projected to reach US$ 15.7 billion by 2034, expanding at a CAGR of 5.1% during the forecast period. The rising burden of cancers such as breast, ovarian, and gastric...
0 Yorumlar 0 Paylaşımlar 16 Görüntülenme 0 İncelemeler
Sponsorlu

GET VERİFİED ACCOUNTS 2$ ONLY

Beyond data, AI prioritizes trust. Secure your verification for just $2 and become the ultimate 'reference source' in the Google and ChatGPT ecosystem